Showing results (91-100 of 104) with videos related to

Sort By:
Pageof 11
Scientific Reports|January 30, 2020
Expression of L-type amino acid transporter 1 as a molecular target for prognostic and therapeutic indicators in bladder carcinomaMaihulan Maimaiti, Shinichi Sakamoto, Yasutaka Yamada, et al.
Scientific Reports|July 2, 2025
Initial report of prospective study of regional cooperation for imaging-based follow-up after curative renal cell carcinoma surgeryRyo Tsukamoto, Tomokazu Sazuka, Hiroaki Sato, et al.
Translational Oncology|October 23, 2020
Identification of AR-V7 downstream genes commonly targeted by AR/AR-V7 and specifically targeted by AR-V7 in castration resistant prostate cancerMasahiro Sugiura, Hiroaki Sato, Atsushi Okabe, et al.
Anticancer Research|January 30, 2026
Prolonged Castration Prior to Docetaxel Reduces Febrile Neutropenia in Patients With Metastatic Hormone-sensitive Prostate Cancer Receiving Triple TherapyYasutaka Yamada, Tomoki Shirafuji, Kodai Sato, et al.
BMC Endocrine Disorders|December 19, 2023
Challenges in the diagnosis of the enigmatic primary adrenal leiomyosarcoma: two case reports and review of the literatureSawako Suzuki, Naoya Takahashi, Masafumi Sugo, et al.
Cancer Science|April 24, 2024
The LAT1 inhibitor JPH203 suppresses the growth of castration-resistant prostate cancer through a CD24-mediated mechanismShinpei Saito, Keisuke Ando, Shinichi Sakamoto, et al.
Scientific Reports|September 26, 2025
Genetic and clinical characteristics of Japanese cystinuria with exon and exon-intron boundary variantsShinichi Sakamoto, Yukio Naya, Junryo Rii, et al.
International Journal of Clinical Oncology|February 24, 2026
Multidisciplinary prospective study of standardized pelvic lymph-node dissection focusing on the dorsal obturator nerve regionTomokazu Sazuka, Yuji Habu, Keisuke Matsusaka, et al.
International Journal of Clinical Oncology|December 10, 2024
Characterization of PSA dynamics and oncological outcomes in patients with metastatic hormone-sensitive prostate cancer treated with androgen receptor signaling inhibitorsYasutaka Yamada, Kodai Sato, Shinichi Sakamoto, et al.
Prostate International|April 11, 2025
Clinical significance of primary tumor progression in metastatic hormone-sensitive prostate cancerYasutaka Yamada, Shinichi Sakamoto, Takuya Tsujino, et al.
Pageof 11